Related Experiment Video
Updated: Aug 17, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss
Suresh B Boppana1, Karen B Fowler, Robert F Pass
1Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama 35233, USA. sboppana@peds.uab.edu
Insights
Infants with higher virus levels in urine and blood during infancy face increased risk of hearing loss from congenital cytomegalovirus (CMV) infection. Early detection and monitoring of CMV viral load are crucial for managing hearing outcomes.
Area of Science:
- Virology
- Pediatrics
- Infectious Diseases
Background:
- Congenital cytomegalovirus (CMV) infection is a leading cause of sensorineural hearing loss in children.
- The relationship between viral burden in infancy and the development of hearing loss in congenital CMV infection requires further elucidation.
Purpose of the Study:
- To investigate the association between the viral load of cytomegalovirus (CMV) in infancy and the incidence of hearing loss in infants diagnosed with congenital CMV infection.
Main Methods:
- A cohort study monitored 76 infants with congenital CMV infection identified via newborn screening.
- CMV viral load was quantified in urine specimens and peripheral blood (PB) DNA using real-time quantitative polymerase chain reaction.
Main Results:
- Symptomatic congenital CMV infants exhibited higher CMV levels in urine and PB compared to asymptomatic infants.
- Among asymptomatic infants, those who developed hearing loss had significantly higher CMV levels in urine and PB during infancy.
- Lower CMV viral loads in urine (< 5 x 10(3) pfu/mL) and PB (< 1 x 10(4) copies/mL) were associated with a reduced risk of hearing loss.
Conclusions:
- Increased CMV viral burden in urine and PB during early infancy is linked to hearing loss in infants with asymptomatic congenital CMV infection.
- These findings highlight the importance of monitoring viral load in congenital CMV infection to predict hearing loss risk.
Objective:
To determine the relationship between the virus burden in infancy and hearing loss in congenital CMV infection.
Study Design:
A cohort of 76 infants with congenital cytomegalovirus (CMV) infection identified by means of newborn virologic screening was monitored for outcome. The amount of infectious CMV was analyzed in urine specimens obtained during early infancy. Peripheral blood (PB) samples obtained during early infancy were available from 75 children and CMV DNA was quantitated with a real-time quantitative polymerase chain reaction.
Results:
Infants with clinical abnormalities at birth (symptomatic congenital CMV infection) had higher amounts of CMV in urine (P = .005) and CMV DNA in PB (P = .001) than infants with no symptoms. Eight children with and 4 children without symptoms had hearing loss. Among children without symptoms, those with hearing loss had a significantly greater amount of CMV in urine (P = .03) and PB virus burden (P = .02) during infancy than those with normal hearing. Infants with < 5 x 10(3) pfu/mL of urine CMV and infants with < 1 x 10(4) copies/mL of viral DNA in PB were at a lower risk for hearing loss.
Conclusion:
In children with asymptomatic congenital CMV infection, hearing loss was associated with increased amounts of urine CMV and PB CMV DNA during early infancy.
Related Concept Videos
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Cryptococcal Meningitis
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Human Virome

